Tandem Health raises $100M to grow from AI scribe into a full clinic operating system
The Stockholm startup's Series B, led by the EU-backed Scaleup Europe Fund, is aimed at expanding beyond AI-generated medical notes into scheduling, triage and patient communications for European clinics.
Tandem Health, a Stockholm-based healthtech startup, has raised $100 million in a Series B led by the Scaleup Europe Fund, an EU-backed vehicle managed by EQT, with existing investors Kinnevik, Northzone, Amino Collective and Visionaries also participating. The round follows a $50 million Series A in 2025 and brings the company's total funding to $160 million.
Tandem's core product is an LLM-powered co-pilot that generates medical notes during patient consultations -- the company says it's now used by 10,000 care organizations across 14 European markets, with the UK, where NHS clinicians use it, as its largest market. The roughly 170-person company says the new capital goes toward two things: deepening its position with European care providers, and expanding from an AI medical assistant into what it calls an AI-native "Clinic Operating System" that would also handle patient flow, triage, scheduling and patient communications.
CEO and co-founder Lukas Saari framed the raise as a sovereignty argument as much as a product one, saying Tandem was built to give European clinics an alternative: "Europe should be setting the standard for how AI enters healthcare, not adopting someone else's."
Tandem's bet, and what decides whether this round turns into value rather than another AI tool bought and left half-used, is whether an AI co-pilot that saves clinicians documentation time gets adopted deeply enough, and widely enough across a clinic's other workflows, to show up as measurable time or cost saved rather than a line item nobody uses.